phenylalanine has been researched along with HIV Coinfection in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (8.33) | 29.6817 |
2010's | 16 (66.67) | 24.3611 |
2020's | 6 (25.00) | 2.80 |
Authors | Studies |
---|---|
Crabtree, AM; Li, S; Lund-Andersen, PK; Patel, JS; Rowley, PA; Rubenstein, BM; Yang, J; Ytreberg, FM | 1 |
Bazotte, RB; Fregonesi, N; Martins, LG; Tasic, L; Visentainer, JEL | 1 |
Annamalai, AS; Asturias, F; Bester, S; Briganti, L; Courouble, VV; Engelman, AN; Francis, AC; Griffin, PR; Haney, R; Huang, SW; Hudait, A; Iqbal, N; KewalRamani, VN; Kvaratskhelia, M; Melikyan, GB; Shkriabai, N; Singh, PK; Voth, GA; Wei, G | 1 |
Bachmann, N; Campbell, EM; Dharan, A; Talley, S; Zwikelmaier, V | 1 |
Carrico, AW; Chahine, A; Cohn, M; Dilworth, SE; Fuchs, D; Gouse, H; Lee, J; Lee, JY; Magidson, JF; Meade, CS | 1 |
Harrison, L; Peacock, TP; Spencer, M; Sumner, RP; Touizer, E; Towers, GJ; Zuliani-Alvarez, L | 1 |
Reardon, S | 1 |
Chen, CH; Cocklin, S; Jing, L; Kang, D; Lee, KH; Liu, X; Meuser, ME; Tian, Y; Wu, G; Zalloum, WA; Zhan, P; Zhang, F | 1 |
Addai, A; Aiken, C; Balasubramaniam, M; Dash, C; Martinez, P; Pandhare, J; Zhou, J | 1 |
Aiken, C; Ambrose, Z; Ferhadian, D; Fischer, DK; Francis, AC; Halambage, UD; Melikyan, GB; Saito, A; Siddiqui, MA; Yamashita, M | 1 |
Fossen, T; Friedrich, M; Frøystein, NA; Hahn, F; Henklein, P; Rauch, P; Schubert, U; Setz, C; Solbak, SM; Votteler, J | 1 |
Aiken, C; Chin, JW; Essig, S; Fletcher, AJ; Halambage, UD; Jacques, DA; James, LC; McEwan, WA; Price, AJ | 1 |
Alam, SL; Bhattacharya, A; Demeler, B; Diaz-Griffero, F; Fricke, T; Ganser-Pornillos, BK; Ivanov, DN; Pornillos, O; Sedzicki, J; Taylor, AB; Yeager, M; Zadrozny, K | 1 |
Foley, D; Hope, TJ; Hulme, AE; Kelley, Z | 1 |
Aiken, C; Halambage, UD; James, LC; Price, AJ; Zhou, J | 1 |
Fuchs, D; Grahmann, AV; Klieber, M; Ledochowski, M; Neurauter, G; Sperner-Unterweger, B; Zeimet, A | 1 |
Fuchs, D; Kitchen, M; Kurz, K; Neurauter, G; Sarcletti, M; Zangerle, R | 1 |
Leal, E; Villanova, FE | 1 |
Brown, RE; Ghannoum, MA; Gillevet, PM; Jurevic, RJ; Mukherjee, PK; Retuerto, M; Sikaroodi, M; Webster-Cyriaque, J | 1 |
Biasin, M; Cagliani, R; Caruz, A; Clerici, M; De Luca, M; Forni, D; Lo Caputo, S; Macías, J; Mazzotta, F; Pineda, JA; Saulle, I; Sironi, M | 1 |
Arien, KK; Fackler, OT; Geyer, M; Iannucci, V; Meuwissen, PJ; Naessens, E; Saksela, K; Stolp, B; Vanham, G; Verhasselt, B; Vermeire, J | 1 |
Ariën, KK; Grupping, K; Heyndrickx, L; Kessler, P; Martin, L; Michiels, J; Selhorst, P; Vanham, G; Vereecken, K | 1 |
Chin, JW; Elliott, T; Fletcher, AJ; James, LC; KewalRamani, VN; Lee, K; Price, AJ; Schaller, T; Towers, GJ | 1 |
Lloyd, AG; Muesing, MA; Mulder, LC; Ng, YS; Simon, V | 1 |
24 other study(ies) available for phenylalanine and HIV Coinfection
Article | Year |
---|---|
Defining the HIV Capsid Binding Site of Nucleoporin 153.
Topics: Amino Acids; Animals; Binding Sites; Capsid; Capsid Proteins; Glycine; HIV Infections; HIV-1; Humans; Nuclear Pore Complex Proteins; Phenylalanine | 2022 |
Metabolite variations in the sera of HIV+ patients after an oral administration of effervescent glutamine and in comparison to non-HIV individuals by NMR.
Topics: Administration, Oral; Glutamine; HIV Infections; Humans; Phenylalanine; Pilot Projects; Tyrosine | 2023 |
Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection.
Topics: Anti-HIV Agents; Capsid Proteins; Drugs, Investigational; Glycine; HIV Infections; HIV-1; Host Microbial Interactions; Humans; mRNA Cleavage and Polyadenylation Factors; Nuclear Pore Complex Proteins; Phenylalanine; Prions; Virus Integration | 2022 |
Nuclear pore blockade reveals that HIV-1 completes reverse transcription and uncoating in the nucleus.
Topics: Active Transport, Cell Nucleus; Capsid; Capsid Proteins; CD4-Positive T-Lymphocytes; Cell Nucleus; Cytoplasm; HEK293 Cells; HeLa Cells; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Indoles; Macrophages; Nuclear Pore; Phenylalanine; Reverse Transcription; Virus Replication | 2020 |
Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biotransformation; Cross-Sectional Studies; HIV Infections; Homosexuality, Male; Humans; Impulsive Behavior; Kynurenine; Male; Methamphetamine; Middle Aged; Phenylalanine; Psychological Tests; Risk-Taking; Substance-Related Disorders; Tryptophan; Tyrosine; Viral Load | 2020 |
Disrupting HIV-1 capsid formation causes cGAS sensing of viral DNA.
Topics: Adaptive Immunity; Antiviral Restriction Factors; Capsid; Cell Line; CRISPR-Cas Systems; DNA, Viral; Gene Editing; Gene Products, gag; HIV Infections; HIV Protease Inhibitors; HIV-1; Host-Pathogen Interactions; Humans; Immunity, Innate; Indoles; Interferons; Macrophages; Membrane Proteins; Mutation; Nucleotidyltransferases; Phenylalanine; Signal Transduction; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Virus Replication | 2020 |
Genetically modified bacteria enlisted in fight against disease.
Topics: Animals; Bacteria; Bacteroides; Biological Therapy; Clinical Trials as Topic; Colitis; Escherichia coli; Gene Transfer, Horizontal; HIV Infections; Humans; Lactobacillus; Lactococcus lactis; Mice; Phenylalanine; Phenylketonurias | 2018 |
Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library.
Topics: Anti-HIV Agents; Capsid; Click Chemistry; HIV Infections; HIV-1; Humans; Molecular Dynamics Simulation; Phenylalanine; Small Molecule Libraries | 2018 |
PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex.
Topics: Anti-HIV Agents; Capsid; Capsid Proteins; Cell Line; DNA, Viral; HEK293 Cells; HIV Infections; HIV Seropositivity; HIV-1; Humans; Indoles; Phenylalanine; Reverse Transcription; Virus Integration; Virus Replication | 2019 |
A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.
Topics: Amino Acid Sequence; Anti-HIV Agents; Capsid; Capsid Proteins; Cell Line, Tumor; Disease Resistance; DNA, Viral; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Indoles; Mutation; Nucleotidyltransferases; Phenylalanine; Protein Stability | 2019 |
Mutation of the highly conserved Ser-40 of the HIV-1 p6 gag protein to Phe causes the formation of a hydrophobic patch, enhances membrane association, and polyubiquitination of Gag.
Topics: Amino Acid Sequence; Antigen Presentation; Cell Membrane; Epitopes; gag Gene Products, Human Immunodeficiency Virus; HeLa Cells; HIV Infections; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Mutation, Missense; Phenylalanine; Proteasome Endopeptidase Complex; Protein Domains; Serine; Ubiquitin-Protein Ligases; Ubiquitination; Virion; Virus Release | 2014 |
Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly.
Topics: Anti-HIV Agents; Binding Sites; Capsid; Capsid Proteins; HIV Infections; HIV-1; Humans; Indoles; Ligands; Models, Molecular; Models, Structural; mRNA Cleavage and Polyadenylation Factors; Mutation; Nuclear Pore Complex Proteins; Phenylalanine; Polycyclic Compounds; Polymerization; Protein Binding; Protein Structure, Tertiary; Reverse Transcription; Virion | 2014 |
Structural basis of HIV-1 capsid recognition by PF74 and CPSF6.
Topics: Capsid; Crystallography, X-Ray; HIV Infections; HIV-1; Indoles; mRNA Cleavage and Polyadenylation Factors; Nuclear Pore Complex Proteins; Phenylalanine; Protein Binding | 2014 |
Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
Topics: Anti-HIV Agents; Capsid; Cell Line; Cell Nucleus; HEK293 Cells; HeLa Cells; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Indoles; Phenylalanine; Virus Replication; Virus Uncoating | 2015 |
HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
Topics: Amino Acid Substitution; Anti-HIV Agents; beta Karyopherins; Binding Sites; Capsid; Capsid Proteins; CD4-Positive T-Lymphocytes; Cell Line; Drug Resistance, Viral; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Indoles; Macrophages; Molecular Chaperones; mRNA Cleavage and Polyadenylation Factors; Nuclear Pore Complex Proteins; Phenylalanine; Protein Binding; Protein Conformation; RNA Interference; RNA, Small Interfering; Virus Internalization; Virus Replication | 2015 |
Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8.
Topics: Biomarkers; Biomarkers, Tumor; Cystadenocarcinoma; Endometrial Neoplasms; Female; HIV Infections; Humans; Isoprostanes; Lymphocyte Activation; Neoplasm Staging; Neopterin; Ovarian Neoplasms; Oxidative Stress; Phenylalanine; Receptors, Tumor Necrosis Factor, Type II; Sepsis; Tyrosine; Uterine Neoplasms | 2008 |
Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy.
Topics: Aged; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Female; HIV Infections; HIV-1; Humans; Lymphocyte Count; Male; Middle Aged; Neopterin; Phenylalanine; Phenylalanine Hydroxylase; RNA, Viral; Tyrosine | 2010 |
Diversity of HIV-1 subtype B: implications to the origin of BF recombinants.
Topics: env Gene Products, Human Immunodeficiency Virus; HIV Infections; HIV-1; Humans; Phenylalanine; Phylogeny; Tryptophan | 2010 |
Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets.
Topics: Adult; Anti-HIV Agents; Case-Control Studies; Chromatography, Liquid; Female; Gas Chromatography-Mass Spectrometry; HIV Infections; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Mouth; Phenylalanine; Tyrosine | 2013 |
A common polymorphism in TLR3 confers natural resistance to HIV-1 infection.
Topics: Cells, Cultured; Cohort Studies; Genetic Predisposition to Disease; Genetic Variation; HIV Infections; HIV Seronegativity; Humans; Italy; Leucine; Male; Phenylalanine; Polymorphism, Genetic; Prospective Studies; Spain; Toll-Like Receptor 3 | 2012 |
Identification of a highly conserved valine-glycine-phenylalanine amino acid triplet required for HIV-1 Nef function.
Topics: Actin Cytoskeleton; Alleles; Amino Acid Motifs; Amino Acid Sequence; Conserved Sequence; Genes, MHC Class I; Glycine; HeLa Cells; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Jurkat Cells; Lymphocytes; nef Gene Products, Human Immunodeficiency Virus; p21-Activated Kinases; Phenylalanine; Proto-Oncogene Proteins c-hck; Receptors, CXCR4; Sequence Deletion; Signal Transduction; Structure-Activity Relationship; trans-Golgi Network; Valine; Virus Replication | 2012 |
MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.
Topics: Antibodies, Monoclonal; Binding Sites; CD4 Antigens; Drug Resistance, Viral; Epitopes; HEK293 Cells; HIV Antibodies; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Microbial Sensitivity Tests; Mutation; Peptides; Phenylalanine; Protein Conformation; Virus Attachment; Virus Internalization | 2012 |
CPSF6 defines a conserved capsid interface that modulates HIV-1 replication.
Topics: Amino Acid Sequence; Antiviral Agents; beta Karyopherins; Capsid Proteins; Cell Line, Tumor; Conserved Sequence; Crystallography, X-Ray; HIV Infections; HIV-1; Humans; Indoles; Models, Molecular; Molecular Chaperones; Molecular Sequence Data; mRNA Cleavage and Polyadenylation Factors; Mutation; Nuclear Pore Complex Proteins; Phenylalanine; Protein Binding; Sequence Alignment; Virus Internalization; Virus Replication | 2012 |
Characterization of HIV-1 integrase N-terminal mutant viruses.
Topics: Amino Acid Substitution; Cells, Cultured; HIV Infections; HIV Integrase; HIV-1; Humans; Leukocytes, Mononuclear; Mutation; Phenylalanine; Virus Integration; Virus Replication | 2007 |